For instance, PDE4A expression is elevated in central nervous system tumor cells [12,15], and PDE4B expression in increased in hematologic malignancies [16,17], whereas hypermethylation of PDE4C promoter sites was reported in high-grade glioma samples [18]. The gene discussed is PDE4A; the disease is central nervous system cancer.